Latest News

Pivot International Acquires Wideblue

Mark Dohnalek, CEO of Pivot International states “This acquisition further expands our European scale of operations and positions Pivot for substantial European growth as a result.”

The acquisition is Pivot’s fifth in the last 24 months continuing its substantial growth trajectory since 2012.

Mark Dohnalek, Pivot International President and Chief Executive Officer describes the company’s growth strategy as “an aggressive calibrated approach to organic and acquired competencies, expertise and assets to help customers meet market needs and global clients needs most effectively. “

Pivot International Acquires Wideblue

Congratulations to Park Mains High School in getting through to the UK finals of the school 4×4 challenge

Congratulations to Park Mains High School, Erskine in getting through to the UK finals of the school 4×4 challenge which will take place at Jaguar Land Rover Headquarters in March 2018. Wideblue supported the school team of S6 pupils with the preparation of a car body shell made from a biodegradable wood chip based thermo forming material. The team were delighted to win the top Innovation prize and were second overall in the regional finals of the Professional Class. Team leader Lewis said “We were delighted with the sponsorship and support from Wideblue. This was the first time Park Mains High School has entered this competition and getting through to the finals in the professional class at Jaguar Land Rover is superb”.

Wideblue, Fraunhofer and Mologic announce new development project for antibiotic susceptibility test for UTIs

Wideblue, along with Fraunhofer and Mologic, are to develop a new point-of-care tester for rapid diagnosis of bacterial urinary tract infections (UTIs) and any associated antibiotic susceptibility, in a primary care setting. The consortium secured £900k of funding for the project from SBRI. During the project Wideblue will integrate the technology from the partners and develop the point of care tester to ensure the device meets the optical and regulatory requirements. Mologic will develop the In Vitro Diagnostics (IVD), Fraunhofer and Kelvin Nanotechnology will develop the optical test waveguides and microfluidics and Barclay Medical Practice will advise on user requirements. The project is a good fit with Wideblue’s skills and experience using the Company’s optical design, electronics, software and mechanical engineering skills together with its ergonomics, prototyping and manufacturing expertise.

Wideblue, together with partners GSS and CRiL, win Electra European Electronics Industry Award 2017

Wideblue together with partners GSS and CRiL win Electra European Electronics Industry Award 2017 for the design of the CRiL N Tidal C capnometer. The team won Best Design Team and Best Medical Device in the 2017 awards which were held in London on 6th Dec 2017. The new medical device, designed and manufactured by Wideblue and using a GSS sensor, has shown very promising results in CRiL clinical trials with COPD patients. Further clinical trials are underway with patients suffering from other respiratory diseases.

Wideblue demonstrate the HCC Hyperspectral Crop Camera and the Peek Retina mobile phone ophthalmoscope

Wideblue were pleased to showcase some recent product developments at the recent Censis Technology Summit and Conference held at the Glasgow Royal Concert Hall, each using sensors in a unique way. The HCC hyperspectral crop camera is an advanced prototype for a product used to manage the health of high value crops at a price point that will be affordable for use on small to medium sized farms. The Peek retina mobile phone ophthalmoscope is a product currently being used to monitor eye health across the world. Wideblue were one of many exhibiters at the technology summit that was a showcase for many different sensor based technologies.